Cargando…
Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel
BACKGROUND: With more countries exiting lockdown, public health safety requires screening measures at international travel entry points that can prevent the reintroduction or importation of the severe acute respiratory syndrome-related coronavirus-2. Here, we estimate the number of cases captured, q...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499710/ https://www.ncbi.nlm.nih.gov/pubmed/32841354 http://dx.doi.org/10.1093/jtm/taaa141 |
_version_ | 1783583734535028736 |
---|---|
author | Dickens, Borame L Koo, Joel R Lim, Jue Tao Sun, Haoyang Clapham, Hannah E Wilder-Smith, Annelies Cook, Alex R |
author_facet | Dickens, Borame L Koo, Joel R Lim, Jue Tao Sun, Haoyang Clapham, Hannah E Wilder-Smith, Annelies Cook, Alex R |
author_sort | Dickens, Borame L |
collection | PubMed |
description | BACKGROUND: With more countries exiting lockdown, public health safety requires screening measures at international travel entry points that can prevent the reintroduction or importation of the severe acute respiratory syndrome-related coronavirus-2. Here, we estimate the number of cases captured, quarantining days averted and secondary cases expected to occur with screening interventions. METHODS: To estimate active case exportation risk from 153 countries with recorded coronavirus disease-2019 cases and deaths, we created a simple data-driven framework to calculate the number of infectious and upcoming infectious individuals out of 100 000 000 potential travellers from each country, and assessed six importation risk reduction strategies; Strategy 1 (S1) has no screening on entry, S2 tests all travellers and isolates test-positives where those who test negative at 7 days are permitted entry, S3 the equivalent but for a 14 day period, S4 quarantines all travellers for 7 days where all are subsequently permitted entry, S5 the equivalent for 14 days and S6 the testing of all travellers and prevention of entry for those who test positive. RESULTS: The average reduction in case importation across countries relative to S1 is 90.2% for S2, 91.7% for S3, 55.4% for S4, 91.2% for S5 and 77.2% for S6. An average of 79.6% of infected travellers are infectious upon arrival. For the top 100 exporting countries, an 88.2% average reduction in secondary cases is expected through S2 with the 7-day isolation of test-positives, increasing to 92.1% for S3 for 14-day isolation. A substantially smaller reduction of 30.0% is expected for 7-day all traveller quarantining, increasing to 84.3% for 14-day all traveller quarantining. CONCLUSIONS: The testing and isolation of test-positives should be implemented provided good testing practices are in place. If testing is not feasible, quarantining for a minimum of 14 days is recommended with strict adherence measures in place. |
format | Online Article Text |
id | pubmed-7499710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-74997102020-09-21 Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel Dickens, Borame L Koo, Joel R Lim, Jue Tao Sun, Haoyang Clapham, Hannah E Wilder-Smith, Annelies Cook, Alex R J Travel Med Original Article BACKGROUND: With more countries exiting lockdown, public health safety requires screening measures at international travel entry points that can prevent the reintroduction or importation of the severe acute respiratory syndrome-related coronavirus-2. Here, we estimate the number of cases captured, quarantining days averted and secondary cases expected to occur with screening interventions. METHODS: To estimate active case exportation risk from 153 countries with recorded coronavirus disease-2019 cases and deaths, we created a simple data-driven framework to calculate the number of infectious and upcoming infectious individuals out of 100 000 000 potential travellers from each country, and assessed six importation risk reduction strategies; Strategy 1 (S1) has no screening on entry, S2 tests all travellers and isolates test-positives where those who test negative at 7 days are permitted entry, S3 the equivalent but for a 14 day period, S4 quarantines all travellers for 7 days where all are subsequently permitted entry, S5 the equivalent for 14 days and S6 the testing of all travellers and prevention of entry for those who test positive. RESULTS: The average reduction in case importation across countries relative to S1 is 90.2% for S2, 91.7% for S3, 55.4% for S4, 91.2% for S5 and 77.2% for S6. An average of 79.6% of infected travellers are infectious upon arrival. For the top 100 exporting countries, an 88.2% average reduction in secondary cases is expected through S2 with the 7-day isolation of test-positives, increasing to 92.1% for S3 for 14-day isolation. A substantially smaller reduction of 30.0% is expected for 7-day all traveller quarantining, increasing to 84.3% for 14-day all traveller quarantining. CONCLUSIONS: The testing and isolation of test-positives should be implemented provided good testing practices are in place. If testing is not feasible, quarantining for a minimum of 14 days is recommended with strict adherence measures in place. Oxford University Press 2020-08-25 /pmc/articles/PMC7499710/ /pubmed/32841354 http://dx.doi.org/10.1093/jtm/taaa141 Text en © International Society of Travel Medicine 2020. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Dickens, Borame L Koo, Joel R Lim, Jue Tao Sun, Haoyang Clapham, Hannah E Wilder-Smith, Annelies Cook, Alex R Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel |
title | Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel |
title_full | Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel |
title_fullStr | Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel |
title_full_unstemmed | Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel |
title_short | Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel |
title_sort | strategies at points of entry to reduce importation risk of covid-19 cases and reopen travel |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499710/ https://www.ncbi.nlm.nih.gov/pubmed/32841354 http://dx.doi.org/10.1093/jtm/taaa141 |
work_keys_str_mv | AT dickensboramel strategiesatpointsofentrytoreduceimportationriskofcovid19casesandreopentravel AT koojoelr strategiesatpointsofentrytoreduceimportationriskofcovid19casesandreopentravel AT limjuetao strategiesatpointsofentrytoreduceimportationriskofcovid19casesandreopentravel AT sunhaoyang strategiesatpointsofentrytoreduceimportationriskofcovid19casesandreopentravel AT claphamhannahe strategiesatpointsofentrytoreduceimportationriskofcovid19casesandreopentravel AT wildersmithannelies strategiesatpointsofentrytoreduceimportationriskofcovid19casesandreopentravel AT cookalexr strategiesatpointsofentrytoreduceimportationriskofcovid19casesandreopentravel |